Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea

Helicobacter

Volumn 13, Issue 4, 2008, Pages 288-294

  Lee, Jung Hoon ^b   Kim, Nayoung ^a   Chung, Jae I I ^a   Kang, Kyung Phil ^a   Lee, Sang Hyup ^a   Park, Young Soo ^a,b   Hwang, Jin Hyeok ^a,b   Kim, Jin Wook ^a   Jeong, Sook Hyang ^a   Lee, Dong Ho ^a,b   Jung, Hyun Chae ^b   Song, In Sung ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Helicobacter pylori IgG; Recrudescence; Reinfection

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; IMMUNOGLOBULIN G ANTIBODY; PANTOPRAZOLE; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ANTIBODY TITER; ARTICLE; ATROPHIC GASTRITIS; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; REINFECTION; SEROCONVERSION; SEROLOGY; TREATMENT OUTCOME; AGED; BLOOD; DRUG COMBINATION; IMMUNOLOGY; INTESTINE TUMOR; ISOLATION AND PURIFICATION; KOREA; MICROBIOLOGY; MIDDLE AGED; RECURRENT DISEASE; TIME;

HELICOBACTER PYLORI;

AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INTESTINAL NEOPLASMS; KOREA; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 51049084043     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2008.00616.x     Document Type: Article

References (43)

1. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043-8.
2. NIH consensus conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
3. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-52.
4. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
5. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
6. Eid R, Moss SF. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2002;346:65-7.
7. Gisbert JP, Blanco M, Benito LM, Pajares JM. Value of quantitative serology for confirmation of Helicobacter pylori eradication: an 18-month follow-up study. Clin Infect Dis 2000;30:976-80.
8. Tanaka J, Ohkusa T, Yokoyama T, et al. Host serological response to Helicobacter pylori after successful eradication: long-term follow-up in patients with cured and persistent infection. Aliment PHarmacol THer 2006;2:239-48.
9. Bell GD, Powell KU. Helicobacter pylori reinfection after apparent eradication - the Ipswich experience. Scand J Gastroenterol Suppl 1996;215:96-104.
10. Feydt-Schmidt A, Kindermann A, Konstantopoulos N, et al. Reinfection rate in children after successful Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2002;14:111 9-23.
11. Powell KU, Bell GD, Bolton GH et al. Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med 1994;87:283-90.
12. van der Hulst RW, Rauws EA, Koycu B, et al. Helicobacter pylori infection is virtually absent after successful eradication. J Infect Dis, 1997;176:196-200.
13. Zhou LY, Lin SR, Shen ZY, et al. Five-year follow-up study after Helicobacter pylori eradication: reinfection and peptic ulcer status. CHin J Dig Dis 2003;4:45-8.
14. Kim N, Lim SH, Lee KH, Jung HC, Song IS, Kim CY. Helicobacter pylori reinfection rate and duodenal ulcer recurrence in Korea. J Clin Gastroenterol 1998;27:321-6.
15. Hildebrand P, Bardhan P, Rossi L, et al. Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 2001;121:792-8.
16. Graham DY, Adam E, Reddy GT, et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci 1991;36:1084-8.
17. Pounder RE, Nq D. The prevalence of Helicobacter pylori infection in different countries. Aliment PHarmacol THer 1995;9 (Suppl. 2):33-9.
18. Kim JH, Kim HY, Kim NY, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 2001;16:969-75.
19. Yim JY, Kim N, Choi SH, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-40.
20. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
21. Kim SY, Ahn JS, Ha YJ, et al. Serodiagnosis of Helicobacter pylori infection in Korean patients using enzyme-linked immunosorbent assay. J Immunoassay 1998;19:251-70.
22. Culter AF, Prasad VM, Santogade P. Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am J Med 1998;105:18-20.
23. Vikram K, Anathakrishnan N, Badrinath S. Chronological change in H. pylori antibody titers after treatment and its utility in follow-up. Am J Gastroenterol 2002;97:1563-4.
24. Miernyk KM, Bruden DL, Bruce MG, et al. Dynamics of Helicobacter pylori-specific immunoglobulin G for 2 Years after successful eradication of Helicobacter pylori infection in an American Indian and Alaska native population. Clin Vaccine Immunol 2007;14:85-6.
25. Bergey B, Marchildon P, Peacock J, Meqraud F. What is the role of serology in assessing Helicobacter pylori eradication? Aliment Pharmacol Ther 2003;15:635-9.
26. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F. Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003;17:99-109.
27. Cereijido M, Valdes J, Shoshani L, Contreras RG. Role of tight junctions in establishing and maintaining cell polarity. Annu Rev Physiol 1998;60:161-77.
28. McColl KE, el-Omar E, Gillen D. Interactions between Helicobacter pylori infection, gastric acid secretion and anti-secretary therapy. Br Med Bull 1998;54:121-38.
29. Karens WE Jr, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
30. Kang HY, Kim N, Park YS, et al. Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig Dis Sci 2006;51:2310-5.
31. Plebani M, Basso D, Cassaro M, et al. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996;91:954-8.
32. Soto G, Bautista CT, Roth DE, et al. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis 2003;188:1263-75.
33. Parsonnet J. What is the Helicobacter pylori global reinfection rate? Can J Gastroenterol 2003;17:46B-48B.
34. Cheon JH, Kim N, Lee DH, et al. Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth containing quadruple therapy in Korea. Eur J Gastroenterol Hepatol 2006;18:515-9.
35. Chung WC, Cho YS, Jeong JJ, et al. Eradication rate of Helicobacter pylori according to the disease and therapeutic regimens, and reinfection rate after successful eradication in a tertiary clinic. Korean J Gastroenterol 2003;41:1-8.
36. Goodman KJ, Correa P. Transmission of H. pylori among siblings. Lancet 2000;355:358-62.
37. Kivi M, Tindberg Y, Sorberg M, et al. Concordance of H. pylori strains within families. J Clin Microbiol 2003;41:5604-8.
38. Raymond J, Thiberge JM, Chevalier C, et al. Genetic and transmission analysis of H. pylori strains within a family. Emerg Infect Dis 2004;10:1816-21.
39. Fujimoto Y, Furusyo N, Toyoda K, Takeoka H, Sawayama Y, Hayashi J. Intrafamilial transmission of H. pylori among the population of endemic areas in Japan. Helicobacter 2007;12:170-6.
40. Maherzi A, Bouaziz Abed A, Fendri C, et al. Helicobacter pylori infection: prospective study for asymptomatic Tunisian children. Arch Pediatr 2003;10:204-7.
41. Chen LK, Hwang SJ, Wu TC, Chu CH, Shaw CK. Helicobacter pylori and hepatitis A virus infection in school-aged children on two isolated neighborhood islands in Taiwan. Helicobacter 2003;8:168-72.
42. Steinberg EB, Mendoza CE, Glass R, et al. Prevalence of infection with waterborne pathogens: a seroepidemiologic study in children 6-36 months old in San Juan Sacatepequez, Guatemala. Am J Trop Med Hyg 2004;70:83-8.
43. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:45-51.